These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 22318205

  • 1. Short-term ACE inhibition confers long-term protection against target organ damage.
    Hale TM, Robertson SJ, Burns KD, deBlois D.
    Hypertens Res; 2012 Jun; 35(6):604-10. PubMed ID: 22318205
    [Abstract] [Full Text] [Related]

  • 2. Protection against L-NAME-induced reduction in cardiac output persists even after cessation of angiotensin-converting enzyme inhibitor treatment.
    Biwer LA, Broderick TL, Xu H, Carroll C, Hale TM.
    Acta Physiol (Oxf); 2013 Jan; 207(1):156-65. PubMed ID: 22834875
    [Abstract] [Full Text] [Related]

  • 3. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
    Zhou X, Matavelli LC, Ono H, Frohlich ED.
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F871-9. PubMed ID: 15900021
    [Abstract] [Full Text] [Related]

  • 4. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J, Ortiz MC, O'Valle F, Alcaraz A, Navarro EG, Vargas F, Evangelista S, Atucha NM.
    Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
    [Abstract] [Full Text] [Related]

  • 5. Enalapril attenuates cardiorenal damage in nitric-oxide-deficient spontaneously hypertensive rats.
    Pereira LM, Bezerra DG, Machado DL, Mandarim-de-Lacerda CA.
    Clin Sci (Lond); 2004 Mar; 106(3):337-43. PubMed ID: 14629192
    [Abstract] [Full Text] [Related]

  • 6. Hypertensive target organ damage is attenuated by a p38 MAPK inhibitor: role of systemic blood pressure and endothelial protection.
    Olzinski AR, McCafferty TA, Zhao SQ, Behm DJ, Eybye ME, Maniscalco K, Bentley R, Frazier KS, Milliner CM, Mirabile RC, Coatney RW, Willette RN.
    Cardiovasc Res; 2005 Apr 01; 66(1):170-8. PubMed ID: 15769460
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V, Devereux RB.
    Minerva Cardioangiol; 2002 Jun 01; 50(3):169-74. PubMed ID: 12107398
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V, Rigamonti A, Fioretti S, Bonomo S, Manfredi B, Ferrario P, Bianchi M, Berti F, Muller EE, Rossoni G.
    Eur J Pharmacol; 2005 Jun 15; 516(3):253-9. PubMed ID: 15963975
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T, Honda T, Ohta S, Akashiba A, Takahashi T, Kameda T, Yoshii M, Minami J, Takahashi M, Ono H, Matsuoka H.
    Am J Hypertens; 2006 Dec 15; 19(12):1233-40. PubMed ID: 17161768
    [Abstract] [Full Text] [Related]

  • 17. Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril.
    Bernátová I, Pechánová O, Pelouch V, Simko F.
    J Mol Cell Cardiol; 2000 Feb 15; 32(2):177-85. PubMed ID: 10722795
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS, Gaul SL, Reitz PM, Blaine EH, Ribeiro LT.
    J Hypertens Suppl; 1983 Oct 15; 1(1):53-63. PubMed ID: 6100609
    [Abstract] [Full Text] [Related]

  • 19. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats.
    Takemoto M, Egashira K, Usui M, Numaguchi K, Tomita H, Tsutsui H, Shimokawa H, Sueishi K, Takeshita A.
    J Clin Invest; 1997 Jan 15; 99(2):278-87. PubMed ID: 9005996
    [Abstract] [Full Text] [Related]

  • 20. Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.
    Jovanovic D, Jovovic D, Mihailovic-Stanojevic N, Miloradovic Z, Naumovic R, Dimitrijevic J, Maksic N, Djukanovic L.
    Biomed Pharmacother; 2009 Sep 15; 63(8):571-6. PubMed ID: 19013753
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.